Figure S1 from STAT3 Targets &Lt;i>err-Α</i> to Promote Epithelial–Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells

Jia-Hui Ma,Jie Qi,Shi-Qi Lin,Cai-Yun Zhang,Fang-yuan Liu,Wei-Dong Xie,Xia Li

DOI: https://doi.org/10.1158/1541-7786.22512372

2023-01-01

Abstract:The whole data of Ch-IP (P1-P11).

What problem does this paper attempt to address?

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Data from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.c.6545555.v1

2023-01-01

Abstract:AbstractCancer progression is highly dependent on the ability of cancer cell tumor formation, in which epigenetic modulation plays an essential role. However, the epigenetic factors promoting breast tumor formation are less known. Screened from three-dimensional (3D)-sphere tumor formation model, HMGN5 that regulates chromatin structures became the candidate therapeutic target in breast cancer, though its role is obscure. HMGN5 is highly expressed in 3D-spheres of breast cancer cells and clinical tumors, also an unfavorable prognostic marker in patients. Furthermore, HMGN5 controls tumor formation and metastasis of breast cancer cells in vitro and in vivo. Mechanistically, HMGN5 is governed by active STAT3 transcriptionally and further escorts STAT3 to shape the oncogenic chromatin landscape and transcriptional program. More importantly, interference of HMGN5 by nanovehicle-packaged siRNA effectively inhibits tumor growth in breast cancer cell–derived xenograft mice model.Implications:Our findings reveal a novel feed-forward circuit between HMGN5 and STAT3 in promoting breast cancer tumorigenesis and suggest HMGN5 as a novel epigenetic therapeutic target in STAT3-hyperactive breast cancer.
HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.mcr-22-0241

2022-01-01

Molecular Cancer Research

Abstract:AbstractCancer progression is highly dependent on the ability of cancer cell tumor formation, in which epigenetic modulation plays an essential role. However, the epigenetic factors promoting breast tumor formation are less known. Screened from three-dimensional (3D)-sphere tumor formation model, HMGN5 that regulates chromatin structures became the candidate therapeutic target in breast cancer, though its role is obscure. HMGN5 is highly expressed in 3D-spheres of breast cancer cells and clinical tumors, also an unfavorable prognostic marker in patients. Furthermore, HMGN5 controls tumor formation and metastasis of breast cancer cells in vitro and in vivo. Mechanistically, HMGN5 is governed by active STAT3 transcriptionally and further escorts STAT3 to shape the oncogenic chromatin landscape and transcriptional program. More importantly, interference of HMGN5 by nanovehicle-packaged siRNA effectively inhibits tumor growth in breast cancer cell–derived xenograft mice model.Implications:Our findings reveal a novel feed-forward circuit between HMGN5 and STAT3 in promoting breast cancer tumorigenesis and suggest HMGN5 as a novel epigenetic therapeutic target in STAT3-hyperactive breast cancer.
Supplementary Figure 3 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren Averett Byers,Lixia Diao,Jing Wang,Pierre Saintigny,Luc Girard,Michael Peyton,Li Shen,Youhong Fan,Uma Giri,Praveen K. Tumula,Monique B. Nilsson,Jayanthi Gudikote,Hai Tran,Robert J.G. Cardnell,David J. Bearss,Steven L. Warner,Jason M. Foulks,Steven B. Kanner,Varsha Gandhi,Nancy Krett,Steven T. Rosen,Edward S. Kim,Roy S. Herbst,George R. Blumenschein,J. Jack Lee,Scott M. Lippman,K. Kian Ang,Gordon B. Mills,Waun K. Hong,John N. Weinstein,Ignacio I. Wistuba,Kevin R. Coombes,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/1078-0432.22446704

2023-01-01

Abstract:PDF file - 66K, CDH1 probes vary in their accuracy and dynamic range
Supplementary Data from AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis

Zicheng Sun,Qiwei Jiang,Bing Gao,Xiaomei Zhang,Lang Bu,Lei Wang,Ying Lin,Wei Xie,Jie Li,Jianping Guo

DOI: https://doi.org/10.1158/0008-5472.22633255.v1

2023-01-01

Abstract:Including supplementary figure S1-9
Fig. S9 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406136

2023-01-01

Abstract:Evaluating the effects of Stat3 shRNA, or it in the presence of 100 nM PAF on the invasion of A549 and H460 cells using transwell invasion assay.
STAT3 Targets ERR-α to Promote Epithelial–Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells

Jia-Hui Ma,Jie Qi,Shi-Qi Lin,Cai-Yun Zhang,Fang-Yuan Liu,Wei-Dong Xie,Xia Li

DOI: https://doi.org/10.1158/1541-7786.mcr-18-1194

2019-01-01

Molecular Cancer Research

Abstract:AbstractSTAT3 is constitutively activated in many malignant tumor types and plays an important role in multiple aspects of cancer aggressiveness. In this study, we found that estrogen-related receptor α (ERR-α) correlating with STAT3 was highly expressed in triple-negative breast cancer (TNBC) cell lines and tissues, which was associated with both the pathologic stage and prognosis of patients with TNBC. In vitro studies showed that ERR-α promoted TNBC cell migration and invasion, which was regulated by STAT3. Phosphorylated STAT3 (p-STAT3, Tyr 705) could bind to the promotor of ERR-α, and activate its transcription, which was suggested by luciferase assay and chromatin immunoprecipitation assay. We also found that ERR-α was the key target gene regulated by STAT3 in promoting epithelial–mesenchymal transition (EMT), migration, and invasion. ERR-α upregulated the expression of ZEB1, N-cadherin, and vimentin while downregulated the expression of E-cadherin. Furthermore, in vivo studies showed that ERR-α could increase the metastasis ability of TNBC. Our finding demonstrated that ERR-α was a direct regulatory gene target of p-STAT3, which was enriched for processes involving invasion and metastasis in TNBC and provided insight into TNBC pathogenesis, as well as a potential therapeutic option against TNBC metastasis.Implications:Our research first showed that p-STAT3 (Tyr 705) could bind to the promotor region of ERR-α and promote EMT in TNBC by ZEB1 pathways, thus providing a potential clinical target for TNBC.
Supplementary Figures 1-5 from Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition

Wen-Tai Chiu,Hsueh-Te Lee,Feng-Ju Huang,Kenneth D. Aldape,Jun Yao,Patricia S. Steeg,Cheng-Yang Chou,Zhimin Lu,Keping Xie,Suyun Huang

DOI: https://doi.org/10.1158/0008-5472.22388180.v1

2023-01-01

Abstract:Supplementary Figures 1-5 from Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition
Supplementary Figure 5 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387140.v1

2023-01-01

Abstract:Supplementary Figure 5 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Supplementary Figure S3 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Hong-Lin Jiang,He-Fen Sun,Shui-Ping Gao,Liang-Dong Li,Sheng Huang,Xin Hu,Sheng Liu,Jiong Wu,Zhi-Ming Shao,Wei Jin

DOI: https://doi.org/10.1158/0008-5472.22409472.v1

2023-01-01

Abstract:(A) The relative mtDNA content was analyzed by real-time PCR amplification of mtDNA encoded COX I and nuclear encoded GAPDH. (B) Statistical data of mitochondrial ROS generation in the indicated cells. (C) Western blot analysis of p-SMAD3 and SMAD3 expression in the indicated cells. (D) The migration abilities of indicated cell line were evaluated by Transwell assays in vitro. *** P < 0.005 compared with control. (E) Left: Control and CCCP-treated (20 μM for 2 h) MDA-MB-231 and MDA-MB-231shSSBP1 cells were incubated with or without added FK506 (10 nM). Total cellular protein fractions were subjected to western blot analysis using indicated antibodies. Right: Total cellular protein fractions of MDA-MB-231 cells transfected with CnA and treated with or without FK506 analyzed by western blot analysis using indicated antibodies. (F) Control and CCCP-treated (20 μM for 2 h) MDA-MB-231 and MDA-MB-231shSSBP1 cells were incubated with or without added FK506 (10 nM). Nuclear protein fractions were subjected to western blot analysis using indicated antibodies. (G) Western blot analysis of E-cadherin and Fibronectin expression in the indicated cells.
Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Hong-Lin Jiang,He-Fen Sun,Shui-Ping Gao,Liang-Dong Li,Sheng Huang,Xin Hu,Sheng Liu,Jiong Wu,Zhi-Ming Shao,Wei Jin

DOI: https://doi.org/10.1158/0008-5472.22409469.v1

2023-01-01

Abstract:<p>Supplementary Materials and Methods, Supplementary Figure Legends, Supplementary Table S1 Alteration of SSBP1 protein expression levels in relation to clinicopathological characteristics in breast cancer patients. Supplementary Table S2 Antibodies used in this study. Supplementary Table S3 Primers for plasmid construction. Supplementary Table S4 Primers for ChIP. Supplementary Table S5 iTRAQ: Dysregulated proteins with gene symbol.</p>
Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387134.v1

2023-01-01

Abstract:Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Fig. S14 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406163

2023-01-01

Abstract:Statistical analyses of PAFR, E-cadherin, N-cadherin, vimentin, snail, Zeb-1, pSrc, pJAK2, pStat3, or IL-6 in A549 and H460 tumors stably expressing shPAFR or their respectively control shRNA.
Supplementary Figure S3 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer

Fei Huang,Qiaoni Shi,Yuzhen Li,Linlin Xu,Chi Xu,Fenfang Chen,Hai Wang,Hongwei Liao,Zai Chang,Fang Liu,Xiang H.-F. Zhang,Xin-Hua Feng,Jing-Dong J. Han,Shiwen Luo,Ye-Guang Chen

DOI: https://doi.org/10.1158/0008-5472.22420277.v1

2023-01-01

Abstract:HER2/EGFR signaling enhances Smad3 nuclear accumulation
Fig. S4 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijie Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406151

2023-01-01

Abstract:Effects of PAF/PAFR axis on growth and invasion of Calu-3 and H226 cells in vitro.
Supplementary Figure S6 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer

Fei Huang,Qiaoni Shi,Yuzhen Li,Linlin Xu,Chi Xu,Fenfang Chen,Hai Wang,Hongwei Liao,Zai Chang,Fang Liu,Xiang H.-F. Zhang,Xin-Hua Feng,Jing-Dong J. Han,Shiwen Luo,Ye-Guang Chen

DOI: https://doi.org/10.1158/0008-5472.22420265

2023-01-01

Abstract:S208 phosphorylation is important for Smad3 nuclear accumulation
Supplementary Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Li Liao,Yin-Ling Zhang,Ling Deng,Chao Chen,Xiao-Yan Ma,Lisa Andriani,Shao-Ying Yang,Shu-Yuan Hu,Fang-Lin Zhang,Zhi-Min Shao,Da-Qiang Li

DOI: https://doi.org/10.1158/0008-5472.22433349

2023-01-01

Abstract:Supplementary figures and tables
Supplementary Figure 3 from Genome-wide Profiling of AP-1–Regulated Transcription Provides Insights into the Invasiveness of Triple-Negative Breast Cancer

Chunyan Zhao,Yichun Qiao,Philip Jonsson,Jian Wang,Li Xu,Pegah Rouhi,Indranil Sinha,Yihai Cao,Cecilia Williams,Karin Dahlman-Wright

DOI: https://doi.org/10.1158/0008-5472.22398827.v1

2023-01-01

Abstract:PDF file - 105KB, Fra-1 or c-Jun depletion reduces proliferation.
Fig. S11 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Jie Chen,Tian Lan,Weimin Zhang,Lijia Dong,Nan Kang,Shumin Zhang,Ming Fu,Bing Liu,Kangtai Liu,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22406172

2023-01-01

Abstract:PAF/PAFR axis enhanced the strength and duration of Stat3 activation.
Supplementary Data from PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Tian-Jian Yu,Ying-Ying Liu,Xiao-Guang Li,Bi Lian,Xun-Xi Lu,Xi Jin,Zhi-Ming Shao,Xin Hu,Gen-Hong Di,Yi-Zhou Jiang

DOI: https://doi.org/10.1158/0008-5472.22430035.v1

2023-01-01

Abstract:Figure S1-S13 and Table S1-S3

Figure S1 from STAT3 Targets &Lt;i&gt;err-Α&lt;/i&gt; to Promote Epithelial–Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Data from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure 3 from an Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl As a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Supplementary Data from AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis

Fig. S9 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

STAT3 Targets ERR-α to Promote Epithelial–Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells

Supplementary Figures 1-5 from Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition

Supplementary Figure 5 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Supplementary Figure S3 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Fig. S14 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Supplementary Figure S3 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer

Fig. S4 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Supplementary Figure S6 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer

Supplementary Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Supplementary Figure 3 from Genome-wide Profiling of AP-1–Regulated Transcription Provides Insights into the Invasiveness of Triple-Negative Breast Cancer

Fig. S11 from Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial–Mesenchymal Transition in Non–Small Cell Lung Cancer

Supplementary Data from PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Figure S1 from STAT3 Targets &Lt;i>err-Α</i> to Promote Epithelial–Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells